Might be right. This is not a cure... yet. Even the star patient, Melinda Bachini (cholangiocarcinoma) is not NED as of today, after two separate treatments. Yeah.
Rosenberg and his team keep tweaking the treatment, as a result of us mice. At first, they just harvested T-cells (TILs), grew them in a lab, and then shot them back into some patients. That did not produce stellar results (except in melanoma patients, I believe) until Melinda B. After her good response, I *think* they figured out what the T-cells were attacking and isolated her tumor's mutations. Her second treatment were TILs that were especially grown to attack the mutations they found. Then, it really worked, but she still isn't NED - she has stable disease, no new growth, and slow shrinkage (she posts to a cholangiocarcinoma board like this one). She still goes back to NCI for checkups, and who knows, she may receive a third treatment if they develop something better.
Since her second treatment, I believe Rosenberg and his team have changed the whole experiment to now test for mutations first, and only inject mutation-reactive T-cells back into the patients. So I"m not sure how that phase of the experiment is going, for people with solid tumors, since it's relatively new. This is what Sleen and I are doing. I think the article in
Science last May just reported on the first phase. Sleen? DH of Sleen?
To me it's worth the risk because I've exhausted all other options. This is my last year on the planet if this trial doesn't do anything for me, or if it isn't, I"m hobbling around suffering from the effects of Stivarga which really really suck...
You're healthier and have less cancer (than I do) so maybe you can wait a year and try for it again, or not... If you wait, likely the treatment will better because of us mice who came before you!
It's a gamble for sure, but I think it's worth trying for because it is personalized medicine. your t-cells attacking your mutations.
Karin